Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Pour le traitement d'entretien de l'anmie pernicieuse, la posologie habituelle est de 100 mcg SC/IM, administre une fois par mois
10.2147/IJN.S213883 53 JelovacN.SikiricP.RucmanR.PetekM.MarovicA.PerovicD.et al (1999)
External resources PubMed - Search for "AOD 9604" or "tirzepatide" to access original research papers, systematic reviews, and clinical trial data from peer-reviewed journals ClinicalTrials.gov - Official registry of all ongoing and completed tirzepatide clinical trials including the full SURMOUNT and SURPASS programs FDA Drug Safety and Availability - Official safety communications, prescribing information, and regulatory updates for Mounjaro and Zepbound (tirzepatide) New England Journal of Medicine - Published the primary SURMOUNT-1 trial results and other landmark tirzepatide studies The Obesity Society - Evidence-based clinical guidelines and educational resources on pharmacological approaches to obesity management SeekPeptides provides calculators, protocol guides, and comparison tools that help users work through exactly these kinds of decisions with data rather than guesswork
Part B enrollment changes
US$ 20.82
US$ 24.23
US$ 27.24
US$ 21.05
US$ 23.00
US$ 21.92
US$ 20.03